Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-21-000710
Filing Date
2021-11-15
Accepted
2021-11-15 16:12:10
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc-20210930.htm   iXBRL 10-Q 1582617
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12081
8 EXHIBIT 31.2 ex312_2.htm EX-31.2 11947
9 EXHIBIT 32.1 ex321_3.htm EX-32.1 5791
10 EXHIBIT 32.2 ex322_4.htm EX-32.2 5158
  Complete submission text file 0001753926-21-000710.txt   7074449

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20210930_def.xml EX-101.DEF 203991
3 PRESENTATION tlcc-20210930_pre.xml EX-101.PRE 335195
4 CALCULATION tlcc-20210930_cal.xml EX-101.CAL 69891
5 LABEL tlcc-20210930_lab.xml EX-101.LAB 551146
6 SCHEMA tlcc-20210930.xsd EX-101.SCH 43729
11 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20210930_htm.xml XML 1322745
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 211410677
SIC: 2833 Medicinal Chemicals & Botanical Products